Company news
Wellbeing Digital Sciences Inc. news in 2021
Wellbeing Digital Sciences Inc.'s news releases, calls and decks from 2021, newest first.
Ketamine One Announces 2021 AGSM Results
December 19, 2021
Ketamine One Reports Audited Financial Results for the 2021 Fiscal Year
December 13, 2021
KetamineOne Adds Seattle Location to US Clinical Network
December 8, 2021
KetamineOne Subsidiary KGK Science Helps Client Receive New Dietary Ingredient Status from U.S. FDA
December 2, 2021
Ketamine One Partners with Cognetivity Neurosciences in Collaborative Clinical Study on Depression and PTSD
December 2, 2021
Ketamine One Provides Second Update on Management Cease Trade Order
November 29, 2021
Ketamine One Subsidiary IRP Health Opens Two New Veteran-Focused Clinics
November 16, 2021
Ketamine One Provides Update on Management Cease Trade Order
November 15, 2021
Ketamine One Announces Intention to Submit Draft Registration Statement for Proposed U.S. Initial Public Offering
November 9, 2021
Ketamine One Announces Resignation of Loreto Grimaldi From Board of Directors
November 4, 2021
Ketamine One Announces Virtual Mental Healthcare Platform in Partnership With iHealthOX
November 4, 2021
Ketamine One Announces Late Filing of Annual Financial Statements and Management Cease Trade Order
November 1, 2021
Ketamine One Provides Updated Information for Stock Exchange Listings
October 21, 2021
Ketamine One Features Biostrap as Part of Inaugural Research Studies
October 20, 2021